Qingqing Cai
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
-
- Lymphoma Diagnosis and Treatment 67
- Oncology top 5%
- Viral-associated cancers and disorders 29
- CAR-T cell therapy research 14
- Molecular Biology top 10%
- Immunology top 10%
- Immune Cell Function and Interaction 14
- T-cell and Retrovirus Studies 12
-
- Chronic Lymphocytic Leukemia Research 10
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (2 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Qingqing Cai
170 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 720
- Pathology and Forensic Medicine 571
- Oncology 818
- Molecular Biology 1.2k
- Immunology 362
Countries citing papers authored by Qingqing Cai
This map shows the geographic impact of Qingqing Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqing Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqing Cai more than expected).
Fields of papers citing papers by Qingqing Cai
This network shows the impact of papers produced by Qingqing Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqing Cai. The network helps show where Qingqing Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingqing Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 10 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 11 | |
| 17 | 2021 | 11 | |
| 18 | 2020 | 19 | |
| 19 | 2015 | 55 | |
| 20 | Clinical analysis of prognosis for 96 patients with peripheral T-cell lymphoma | 2007 | 1 |
About Qingqing Cai
Qingqing Cai is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology, having authored 191 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (67 papers), Viral-associated cancers and disorders (29 papers), CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (14 papers), T-cell and Retrovirus Studies (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Cancer-related molecular mechanisms research (10 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (720 citations), Pathology and Forensic Medicine (571 citations) and Oncology (818 citations). Qingqing Cai has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Tianxin Lin, Guangzheng Zhong, Wang He, Ken H. Young, Jian Huang, Junhua Luo, Wen Dong, Na Li, Qing Miao and Bijie Hu. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.